Statera Biopharma, Inc. Increase (Decrease) in Interest Payable, Net
Statera Biopharma, Inc. reported Increase (Decrease) in Interest Payable, Net of $18.45 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2013-11-08
- 2013-09-30: Increase (Decrease) in Interest Payable, Net 9 month $18.45K.
| Period end | Increase (Decrease) in Interest Payable, Net 9 month |
|---|---|
| 2013-09-30 | $18.45K 10-Q · filed 2013-11-08 |